stockrow
Friday 6 November 2026
Export BFLY’s income statement to Excel — free account
Butterfly Network, Inc.
BFLY Healthcare Medical Devices
Butterfly Network, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $97.6 million, up 19.0% from fiscal 2024.
- Revenue
- +51.7%
- EPS
- +63.0%
- Free cash flow
- +12.6%
Quarter to September 2026, against a year earlier
6.35
0.28
+4.61%
Follow BFLY
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
19.37 | 19.68 | 10.07 | 9.62 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(1,053.76) | (135.65) | (74.59) | 103.98 | |
P/B ratio |
12.95 | 11.65 | 5.42 | 4.79 | |
Price to Tangible BV |
13.42 | 12.09 | 5.63 | 4.98 | |
EV/Sales |
18.82 | 19.05 | 9.25 | 8.63 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(99.13) | (88.93) | (63.84) | (66.34) | |
EV/FCF |
(84.19) | (76.18) | (50.49) | (52.50) | |
Quick Ratio |
2.35 | 2.72 | 2.74 | 2.72 | |
Current Ratio |
3.58 | 4.06 | 4.02 | 3.83 | |
Net Debt/EBITDA |
10.22 | 10.38 | 11.44 | 10.06 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.43 | 0.38 | 0.34 | 0.35 | |
Operating CF/Net income |
0.18 | 1.26 | 1.10 | (0.59) | |
Capex/Depreciation |
(0.71) | (0.59) | (0.52) | (0.62) | |
Interest Coverage |
(47.81) | (48.45) | (49.72) | (42.85) | |
Research and Development Expense of Revenue |
31.20% | 32.33% | 35.95% | 29.58% | |
Selling, General and Administrative Expense of Revenue |
71.06% | 69.98% | 83.81% | 73.90% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.03 | 0.03 | |
Share Based Compensation of Revenue |
20.65% | 21.58% | 20.89% | 20.19% | |
Graham Net Nets |
0.06 | 0.07 | 0.14 | 0.16 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(2.32%) | (3.44%) | (7.43%) | (8.16%) | |
Free Cash Flow Yield |
(1.15%) | (1.27%) | (1.82%) | (1.71%) | |
Revenue per Share |
0.12 | 0.12 | 0.10 | 0.13 | |
Operating CF per Share |
(0.01) | (0.06) | (0.05) | 0.04 | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.01) | (0.07) | (0.06) | 0.03 | |
Cash per Share |
0.46 | 0.48 | 0.54 | 0.61 | |
Shareholders Equity per Share |
0.69 | 0.72 | 0.75 | 0.79 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.69 | 0.72 | 0.75 | 0.79 | |
Free Cash Flow |
(3.41) | (17.24) | (14.84) | 7.95 | |
Working Capital |
175.68 | 179.34 | 180.21 | 183.99 | |
Capital Expenditures |
(1.14) | (0.97) | (0.95) | (1.08) | |
Net Current Asset Value |
140.14 | 144.35 | 145.09 | 148.55 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.03 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
30.90 | 29.54 | 22.55 | 23.77 | |
Average Payables |
4.48 | 3.42 | 2.55 | 4.85 | |
Average Inventory |
60.91 | 63.73 | 64.31 | 66.09 | |
Average Assets |
288.99 | 298.14 | 302.17 | 276.31 | |
Average Common Equity |
194.14 | 211.10 | 215.46 | 182.41 |
Columns are period end dates · fundamentals updated 6 Nov 2026